Propranolol (inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: Possible involvement of beat - adrenergic mechanisms

Robert Wilbur , Frank A Kulik
{"title":"Propranolol (inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: Possible involvement of beat - adrenergic mechanisms","authors":"Robert Wilbur ,&nbsp;Frank A Kulik","doi":"10.1016/0364-7722(81)90105-3","DOIUrl":null,"url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. This clinical report describes four psychotic patients with neuroleptic-induced tardive (orofacial) dyskinesia and extrapyramidal side effects who were successfully treated with propranolol 30 – 60 mg per day.</p></span></li><li><span>2.</span><span><p>2. Relief of orofacial symptoms and tremor was marked and rapid (one to ten days). In one case propranolol was stopped and orofacial symptoms emerged.</p></span></li><li><span>3.</span><span><p>3. No side effects were observed.</p></span></li><li><span>4.</span><span><p>4. The literature on propranolol in tardive dyskinesia and tremor disorders is reviewed. Central and peripheral mechanisms are considered, and several specific experiments are proposed to clarify the site of action. It is suggested that clinical investigation with propranolol in tardive dyskinesia and extrapyramidal side effects might enhance our understanding of the possible adrenergic modulation of the dopaminergic/cholinergic balance in the striatum.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"4 6","pages":"Pages 627-632"},"PeriodicalIF":0.0000,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90105-3","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in neuro-psychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0364772281901053","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

Abstract

  • 1.

    1. This clinical report describes four psychotic patients with neuroleptic-induced tardive (orofacial) dyskinesia and extrapyramidal side effects who were successfully treated with propranolol 30 – 60 mg per day.

  • 2.

    2. Relief of orofacial symptoms and tremor was marked and rapid (one to ten days). In one case propranolol was stopped and orofacial symptoms emerged.

  • 3.

    3. No side effects were observed.

  • 4.

    4. The literature on propranolol in tardive dyskinesia and tremor disorders is reviewed. Central and peripheral mechanisms are considered, and several specific experiments are proposed to clarify the site of action. It is suggested that clinical investigation with propranolol in tardive dyskinesia and extrapyramidal side effects might enhance our understanding of the possible adrenergic modulation of the dopaminergic/cholinergic balance in the striatum.

心得安治疗迟发性运动障碍和抗精神病药的锥体外系副作用:可能与肾上腺素能机制有关
1.1. 本临床报告描述了4例精神病患者,他们患有抗精神病药引起的迟发性(口面部)运动障碍和锥体外系副作用,并成功地每天服用30 - 60mg心得安。口面部症状和震颤的缓解明显而迅速(1至10天)。1例停用心得安后出现口面部症状。未见副作用。综述了心得安治疗迟发性运动障碍和震颤障碍的文献。考虑了中枢和外周机制,并提出了几个具体的实验来阐明作用部位。提示应用心得安治疗迟发性运动障碍和锥体外系副作用的临床研究可能有助于我们了解肾上腺素能调节纹状体中多巴胺能/胆碱能平衡的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信